Interestingly, we found the MMTV-HER2/MMTV-MED1 double-transgenic mice show a significantly earlier tumor onset (~6 weeks earlier on average) when compared with that of MMTV-HER2 mice (Figure 2B). Here, ERBB2 is linked to neoplasm.